Alkylating Agents: Clinical Trials

3 trials of Alkylating Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Active not recruiting 1

Follow Alkylating Agents: new trials by email Literature Review of Alkylating Agents trials Research Report on Alkylating Agents

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
Purified regulatory T-cells (Treg) plus CD34+ HSPC, Fludarabine, Melphalan - Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies
Phase 1Active not recruitingStanford University662021-09-072026-05-12
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Cisplatin, Stereotactic Body Radiation Therapy (SBRT) - Squamous Cell Carcinoma of the Head and Neck
Phase 1CompletedH. Lee Moffitt Cancer Center and Research Institute202014-07-162023-01-19
A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer
BIIB022 With Paclitaxel and Carboplatin - Non-Small Cell Lung Cancer
Phase 1CompletedBiogen182009-10-012013-09-16

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Laryngeal Diseases (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Myelodysplastic Syndromes (1)  ·  Myeloproliferative Disorders (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Biogen (1)  ·  H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Stanford University (1)

Countries

United States (3)

Top investigators

Everett Meyer, MD,PhD (1)  ·  Jimmy Caudell, M.D., Ph.D. (1)